Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334,352,960
-
Number of holders
-
231
-
Total 13F shares, excl. options
-
154,414,415
-
Shares change
-
-5,001,017
-
Total reported value, excl. options
-
$1,478,691,442
-
Value change
-
-$53,630,372
-
Put/Call ratio
-
18.05%
-
Number of buys
-
107
-
Number of sells
-
-108
-
Price
-
$9.58
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q3 2022
274 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q3 2022.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 231 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 154,414,415 shares
of 334,352,960 outstanding shares and own 46.18% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (14,253,754 shares), BlackRock Inc. (11,466,492 shares), PERCEPTIVE ADVISORS LLC (10,248,624 shares), STATE STREET CORP (9,932,152 shares), Avoro Capital Advisors LLC (9,020,000 shares), FRANKLIN RESOURCES INC (5,182,146 shares), PRICE T ROWE ASSOCIATES INC /MD/ (4,711,314 shares), PICTET ASSET MANAGEMENT SA (3,982,344 shares), GOLDMAN SACHS GROUP INC (2,994,979 shares), and Artisan Partners Limited Partnership (2,758,573 shares).
This table shows the top 231 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.